Luo Shengkang

Second-Level Chief Physician; Doctoral Supervisor; Expert Recipient of the State Council Special Government Allowance; PhD in Plastic Surgery, Faculty of Biology and Medicine, University of Lausanne / Lausanne University Hospital (CHUV), Switzerland; Discipline Leader, Department of Plastic and Aesthetic Surgery, Guangdong Second Provincial General Hospital.
Member, International Society of Aesthetic Plastic Surgery (ISAPS); President, Minimally Invasive and Dermatologic Aesthetic Surgery Branch, Chinese Association of Plastic and Aesthetics (CAPA); Head, Minimally Invasive Injectable Aesthetics Group, Aesthetic and Plastic Surgeons Branch, Chinese Medical Doctor Association (CMDA); Deputy Head, Breast Plastic Surgery Group, Plastic Surgery Branch, Chinese Medical Association (CMA); Medical Device Technical Review Expert, National Medical Products Administration; Principal Investigator (PI), Clinical Research and Translation Base, National Innovation Center for Advanced Medical Devices.
Principal Investigator of 3 projects funded by the National Natural Science Foundation of China and more than 20 provincial/municipal, industry–academia–research, and commissioned research projects. Principal Investigator of more than 60 multicenter clinical trials of drugs and medical devices, including more than 40 trials in which his institution served as the lead PI site. Author of more than 100 SCI-indexed papers and more than 200 Chinese-language papers. Contributor to national key textbooks for the 14th Five-Year Plan period and chief editor/contributing author of 10 group standards, industry standards, and expert consensuses.
FIMAN Global Lead Tutor. Participated in drafting multiple FIMAN-related group standards, expert consensuses, and clinical studies, including “Specification of facial injection techniques for tissue extraction collagen”, “Expert Consensus on the Standard Operating Procedures for Collagen-Induced Perioral Rejuvenation Filling”, “Expert Consensus on the Operation Specifications of Collagen Periorbital Filling”, and “Research Progress of Classification of Periorbital Aging”; and “A Prospective, Randomized, Active-Controlled, Evaluator-Blinded, Noninferiority Clinical Trial Examining a Non-Cross-Linked Bovine-Derived Type I/III Collagen Filler Combined with Hyaluronic Acid for Periocular Rejuvenation”

